NRG1 and breast cancer: Although the diabetic status of breast cancer patients was unknown, we demonstrated that patients with high NOTCH activity had upregulated NRG1 expression, regardless of breast cancer subtype, and had more accessible chromatin structure within the NRG1 enhancer region.